263 related articles for article (PubMed ID: 31668806)
1. Tripartite motif containing 14: An oncogene in papillary thyroid carcinoma.
Sun W; Wang Y; Li D; Wu Y; Ji Q; Sun T
Biochem Biophys Res Commun; 2020 Jan; 521(2):360-367. PubMed ID: 31668806
[TBL] [Abstract][Full Text] [Related]
2. miR-4443 targets TRIM14 to suppress metastasis and energy metabolism of papillary thyroid carcinoma (PTC) in vitro.
Zuo XM; Sun HW; Fang H; Wu Y; Shi Q; Yu YF
Cell Biol Int; 2021 Sep; 45(9):1917-1925. PubMed ID: 34051007
[TBL] [Abstract][Full Text] [Related]
3. miR-671-5p repressed progression of papillary thyroid carcinoma via TRIM14.
Wang WJ; Yuan Y; Zhang D; Liu P; Liu F
Kaohsiung J Med Sci; 2021 Nov; 37(11):983-990. PubMed ID: 34292652
[TBL] [Abstract][Full Text] [Related]
4. Tripartite motif‑containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway.
Diao W; Zhu C; Guo Q; Cao Y; Song Y; Feng H; Li J; Xue X; Lu P
Mol Med Rep; 2020 Dec; 22(6):5145-5154. PubMed ID: 33174608
[TBL] [Abstract][Full Text] [Related]
5. TRIM14 Overexpression Induces Chemoresistance and Malignant Behaviors of Hepatocellular Carcinoma Cells by Activating the STAT3/HIF-1α Pathway.
Xu W; Zhuang L; Zhu H; Mao A; Zhou J; Wang L
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628777
[TBL] [Abstract][Full Text] [Related]
6. TRIM14 Promotes Breast Cancer Cell Proliferation by Inhibiting Apoptosis.
Hu G; Pen W; Wang M
Oncol Res; 2019 Mar; 27(4):439-447. PubMed ID: 29562956
[TBL] [Abstract][Full Text] [Related]
7. TRIM14 regulates melanoma malignancy via PTEN/PI3K/AKT and STAT3 pathways.
Chen J; Huang L; Quan J; Xiang D
Aging (Albany NY); 2021 May; 13(9):13225-13238. PubMed ID: 33982666
[TBL] [Abstract][Full Text] [Related]
8. TRIM14 Is a Key Regulator of the Type I IFN Response during
Hoffpauir CT; Bell SL; West KO; Jing T; Wagner AR; Torres-Odio S; Cox JS; West AP; Li P; Patrick KL; Watson RO
J Immunol; 2020 Jul; 205(1):153-167. PubMed ID: 32404352
[TBL] [Abstract][Full Text] [Related]
9. Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK/mTOR pathway.
Xiao F; Ouyang B; Zou J; Yang Y; Yi L; Yan H
Drug Dev Res; 2020 Aug; 81(5):544-550. PubMed ID: 32096264
[TBL] [Abstract][Full Text] [Related]
10. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
11. TRIM30 modulates Interleukin-22-regulated papillary thyroid Cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination.
Li W; Li F; Lei W; Tao Z
Cell Commun Signal; 2019 Dec; 17(1):162. PubMed ID: 31823782
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TRIM26 suppresses the proliferation, metastasis, and glycolysis in papillary thyroid carcinoma cells.
Wang K; Chai L; Qiu Z; Zhang Y; Gao H; Zhang X
J Cell Physiol; 2019 Aug; 234(10):19019-19027. PubMed ID: 30927273
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
[TBL] [Abstract][Full Text] [Related]
14. TRIM14 expression is regulated by IRF-1 and IRF-2.
Cui J; Xu X; Li Y; Hu X; Xie Y; Tan J; Qiao W
FEBS Open Bio; 2019 Aug; 9(8):1413-1420. PubMed ID: 31150153
[TBL] [Abstract][Full Text] [Related]
15. Tripartite motif-containing 14 (TRIM14) promotes epithelial-mesenchymal transition via ZEB2 in glioblastoma cells.
Feng S; Cai X; Li Y; Jian X; Zhang L; Li B
J Exp Clin Cancer Res; 2019 Feb; 38(1):57. PubMed ID: 30728039
[TBL] [Abstract][Full Text] [Related]
16. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway.
Su X; Wang J; Chen W; Li Z; Fu X; Yang A
Oncotarget; 2016 Mar; 7(9):9939-50. PubMed ID: 26799420
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M
Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947
[TBL] [Abstract][Full Text] [Related]
19. RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop.
Xiao C; Zhang W; Hua M; Chen H; Yang B; Wang Y; Yang Q
Cell Mol Biol Lett; 2022 May; 27(1):36. PubMed ID: 35562668
[TBL] [Abstract][Full Text] [Related]
20. TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial‑to‑mesenchymal transition via activation of AKT signaling regulated by miR‑195‑5p.
Wang F; Ruan L; Yang J; Zhao Q; Wei W
Oncol Rep; 2018 Dec; 40(6):3273-3284. PubMed ID: 30272351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
